ALDOA and hepatocellular carcinoma: By employing AAV8-mediated liver gene knockdown, the inhibition of DEN-induced HCC formation was notably observed upon Aldoa knockdown in vivo, thereby indicating the potential of ALDOA inhibition as a viable strategy for HCC therapy.